MCAULAY CAMERON (Chief Financial Officer) reported 1 transaction at TRANSPHORM, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/3/2024ACC: 0001209191-24-000524
Officer· Chief Financial Officer
Since Feb 2020
-5.65K
Net shares
Net seller
$20.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.65K
Price / share
$3.65
Trade value
$20.62K
% of position
3.0%
1/1/2024
187.70K→182.05K
Total
Net shares
−5.65K
Net value
-$20.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2024 | F · Tax Withholding | −5.65K | $3.65 | $20.62K | 3.0% | 187.70K | 182.05K |
| Total | −5.65K | -$20.62K | ||||||
Derivative Transactions0
No derivative transactions reported